Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah(The University of Texas MD Anderson Cancer Center), Anthony P. Conley(The University of Texas MD Anderson Cancer Center), Edwin R. Parra(The University of Texas MD Anderson Cancer Center), Heather Lin(The University of Texas MD Anderson Cancer Center), Behrang Amini(The University of Texas MD Anderson Cancer Center), Luisa M. Solis Soto(The University of Texas MD Anderson Cancer Center), Ruth Salazar(The University of Texas MD Anderson Cancer Center), Carmélia Maria Noia Barreto(The University of Texas MD Anderson Cancer Center), Honglei Chen(The University of Texas MD Anderson Cancer Center), Swati Gite(The University of Texas MD Anderson Cancer Center), Cara Haymaker(The University of Texas MD Anderson Cancer Center), Elise F. Nassif(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(The University of Texas MD Anderson Cancer Center), Akash Mitra(The University of Texas MD Anderson Cancer Center), J. Andrew Livingston(The University of Texas MD Anderson Cancer Center), Vinod Ravi(The University of Texas MD Anderson Cancer Center), Dejka M. Araujo(The University of Texas MD Anderson Cancer Center), Robert S. Benjamin(The University of Texas MD Anderson Cancer Center), Shreyaskumar Patel(The University of Texas MD Anderson Cancer Center), Maria A. Zarzour(The University of Texas MD Anderson Cancer Center), Sharjeel Sabir(Scripps Mercy Hospital), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Wei‐Lien Wang(The University of Texas MD Anderson Cancer Center), Najat C. Daw(The University of Texas MD Anderson Cancer Center), Xiao Zhou(The University of Texas MD Anderson Cancer Center), Christina L. Roland(The University of Texas MD Anderson Cancer Center), Zachary A. Cooper(AstraZeneca (United States)), Jaime Rodriguez‐Canales(AstraZeneca (United States)), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Jean‐Charles Soria(Université Paris-Saclay), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Patrick Hwu(Moffitt Cancer Center)
Cited by 154
Abstract
Related Papers
No related papers found
Powered by citation graph analysis